Reliability and Validity of CCISO for Diagnosis of Autism Spectrum Disorder
NCT ID: NCT04511767
Last Updated: 2022-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2019-09-01
2022-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of AAI Dogs on Performance and Behavior of Children with Autism
NCT06609122
Parent-implemented Social Communication Treatment in Autism
NCT05635760
The Relationship Between Social Memory Disorders and Sleep Spindles in Children With Autism Spectrum Disorder
NCT06306378
Psychometric Studies of the Chinese Versions of the SRS, CAST, and AQ
NCT01247662
Parent-implemented Social Communication Treatment in Preschool Children With Autism Spectrum Disorder
NCT05455411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is of importance to accurately distinguish children with ASD from those with Global Developmental Delay (GDD) and Language Disorder (LD) without ASD, sometimes, it's very difficult in children with mental ages below 2 years. This differentiation has strong implications for treatment recommendations and may also inform long-term prognosis. In this study, The investigators planned to recruit 60 children with ASD and 60 children with GDD/LD aged from 18 months to 48 months. The reliability evaluation include test-retest reliability and inter-rater reliability. DSM-5 criterion is used as the gold standard. Validity is assessed by determining the correlation and consistency between CCIOS and DSM-5 criterion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ASD group
the autism spectrum disorder group
Do not take any interventions
Do not take any interventions
GDD group
the global developmental disorder group
Do not take any interventions
Do not take any interventions
LD group
the language disorder group
Do not take any interventions
Do not take any interventions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Do not take any interventions
Do not take any interventions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 months - 48 months;
Exclusion Criteria
18 Months
48 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiu Xu, Doctor
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital of Fudan University
Qiong Xu, Doctor
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital of Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's hospital of Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCIOS2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.